Queen Mary Innovation
  • About Us
    • Our People
    • Our Board
    • Our Partners
  • Our Technologies
    • Why License Technology From QMI
    • Licensing Opportunities
      • Biopharma
      • Technology and Engineering
  • Our Spinouts
    • Spin out Portfolio
  • QMB
  • Innovation China UK
  • News & Events
    • Latest News
    • Careers
  • Contact Us
Select Page

QMUL researchers receive award of £3.48m for the development of cancer therapeutic

by admin | Jan 20, 2021 | News

QMUL researchers receive award of £3.48m for the development of cancer therapeutic Professor Yaohe Wang, Prof of Cancer Cell and Gene Therapy “It’s been a great honour to get this grant with my Co-investigators Prof Nick Lemoine, Drs. Louisa Chard and Dr David...

Bowel Research UK Press release 29.09.20; Lower bowel holds secret to weight loss

by admin | Oct 2, 2020 | News

Bowel Research UK Press release 29.09.20; Lower bowel holds secret to weight loss A human Phase I trial led by Dr Madusha Peiris, supported by Bowel Research UK and the John Moulton Foundation has found that specific nutrients delivered to the colon can reduce food...

QMI awards 5 academics PoC funding to develop their innovative translational research

by admin | Sep 21, 2020 | News

SMD NEWS: QMI awards 5 academics PoC funding to develop their innovative translational research In the past few months, QMUL alongside other UK Universities had to deal with the social restrictions of the coronavirus. However, this did not stop Queen Mary Innovation,...

QMUL spin-out Kinomica has been named as a finalist in the Bioseed “One to watch” category at the OBN (Oxford Biotechnology Network) awards 2020.

by admin | Sep 9, 2020 | News

QMUL spin-out Kinomica has been named as a finalist in the Bioseed “One to watch” category at the OBN (Oxford Biotechnology Network) awards 2020 Advanced proprietary bioinformatics and phosphoproteomics analytical methods developed at QMUL by lead inventor...

Agrin as a potential therapy for cartilage regeneration and pain relief for osteoarthritis- BBC Radio 5 Live, daily newspaper and other media outlets

by admin | Sep 6, 2020 | News

Agrin as a potential therapy for cartilage regeneration and pain relief for osteoarthritis- BBC Radio 5 Live, daily newspaper and other media outlets Prof Francesco Dell’Accio and co-inventor Dr Suzanne Eldridge worked with Queen Mary Innovation to file a patent on a...
« Older Entries

Get in Touch

Queen Mary Innovation Ltd.
Queen Mary University of London
Mile End Road
London E1 4NS
Tel: 020 7882 5391

Copyright © 2021 Queen Mary Innovation|Developed by Identity Creative|Privacy Policy

Resolomics

Business Activity

Resolomics is a biotechnology company developing innovative, high-value companion diagnostics and a novel cell-based therapy. Resolomics initial product focus is on: Rheumatoid Arthritis, Cardiovascular Disease, Sepsis & Trauma where substantial unmet clinical need exists. The technology can be applied across all inflammatory diseases, both chronic and acute.

Founding Academics

Prof. Jesmond Dalli and Prof. Mauro Perretti

Website

Stealthyx Therapeutics Ltd

 


Business Activity

Stealthyx Therapeutics Limited has developed a novel LAP (latent- associated protein) Prothyx biologics delivery platform.  The company’s approach is to develop a safer delivery system – lower doses of drug that are specifically targeted to the site of disease.

Founding Academic

Yuti Chernajovsky, Professor of Molecular Medicine, William Harvey Research Institute

Website

Emdot Ltd

Business Activity

Emdot Limited has developed an electrostatic fluid dispensing technology which is potentially superior to existing piezoelectric inkjet dispensing devices. It offers controlled drop-on-demand dispensing at a drop size ten times smaller than can be achieved with existing technology.

Founding Academic

Dr Mark Paine, Dr Matthew Alexander and Dr Katharine Smith, School of Engineering & Materials Science

VaryDose

Business Activity

VaryDose Limited is developing a dry powder dispensing technology. The technology has the potential to become an enabling manufacturing process in the pharmaceutical industry for dispensing pharmaceutical powders and drugs that are currently in product development pipelines and for which there is currently no dispensing solution. VaryDose has the potential to displace conventional capsule and blister filling technologies.

Founding Academic

Dr Shoufeng Yang, School of Engineering and Materials Science

Degrasense Ltd


Business Activity

Degrasense Limited has developed a novel thin-film hydrogel material that can be used in disposable, instant protease sensors. The material can be adapted to detect different proteases and/or be used in sensor arrays where the detection of complex mixtures of proteases is required.

Founding Academic

Dr Steffi Krause, Reader in Electroanalytical Systems, School of Engineering & Materials Science & Dr Mike Watkinson, Professor of Synthetic Chemistry, School of Biological and Chemical Sciences

Chatterbox Labs

Business Activity

Chatterbox Labs Limited is a Software-as-a-Service (SaaS) platform that will enable corporations to monitor, manage and improve brand reputation and marketing campaigns by identifying dynamic communities of people who are actively communicating with each other around a product or service related topic. This is achieved using data from social media networks, such as Twitter, where users post tweets containing opinions about brands, products or events.

Founding Academic

Matthew Purver, Stuart Battersby, School of Electronic Engineering & Computer Science

Website

Warblr Ltd

Business Activity

Warblr Limited is an app that automatically identifies birds by their song by marching audio recordings with its database of bird species.

Founding Academic

Dan Stowell, Senior Research Fellow, School of Electronic Engineering & Computer Science

Website

Touchkeys Instruments Ltd

Business Activity

TouchKeys Instruments Limited is a technology for adding touch sensing capability to a piano-style digital keyboard. Measuring the movement of the fingers on the key surfaces greatly expands the expressive range of the keyboard, allowing techniques like vibrato, pitch bends and timbre changes to be played easily and intuitively. Unlike other products in the musical controller market, TouchKeys retains the traditional look and feel of the piano keyboard, making them more accessible to pianists, as well as providing a unique solution for piano tutoring and learning.

Founding Academic

Andrew McPherson, Associate Professor in Digital Media, School of Electronic Engineering & Computer Science

Website

Augmented Instruments Ltd

Business Activity

Augmented Instruments Limited focuses on commercialising QMUL tech-based digital audio technology that have no natural licensee but could have significant sales as products, either direct to customers or through established distribution channels. The first product Bela is an embedded audio processing platform based on open source.

Founding Academic

Andrew McPherson, Associate Professor in Digital Media, School of Electronic Engineering & Computer Science

Website

Vision Semantics

Business Activity

Vision Semantics Limited provides unique Video Analytics solutions that are differentiated from the competition by being more discriminative and robust in defining meaningful semantic tags for wide scale Video applications. This includes detecting and tagging objects in a CCTV scene; typical and atypical object movement and type information extracted to profile behaviours captured in CCTV and video; automated semantic-tagging of CCTV recordings based on holistic human presence detection and abnormal event / activity recognition.

Founding Academic

Professor Sean Gong, Professor of Visual Computation, School of Electronic Engineering & Computer Science

Website

FXive Ltd

Business Activity

FXive Limited has created sound synthesis software models that allow interactive, real-time generation of a wide range of sounds, and over a hundred presets for specific sounds. The software is time-saving and has performance benefits to professional film production but, with an appropriate user interface, enable amateur video producers, such as those using YouTube, to improve the quality of their product.

BioMin Technologies Ltd

Business Activity

BioMin Technologies Limited has developed a range of calcium phospho-silicates for use as additives in remineralising toothpastes and professional products for preventing tooth decay and treating dentine hypersensitivity.  The primary activity of the company is the supply of BioMin glass as an additive for toothpaste and professional dental product formulations through developing a global licence holder network for BioMin intellectual property.  The company also sells toothpastes directly through distribution channels.

Founding Academic

Robert Hill, Professor of Physical Sciences in relation to Dentistry, Institute of Dentistry – Barts and The London

Website

Chromosol Ltd

Business Activity

Chromosol Limited is developing an organic sensitized rare earth optical amplifier technology to enter the £3 bn optical transceiver and optical amplifier markets.  The organic optical amplifier material allows fibre optic technology to operate on a much shorter scale, of the order of a metre between racks and servers in datacentres, and on the cm scale between silicon chips in devices.

Founding Academic

William Gillin, Professor of Experimental Physics, School of Physics and Astronomy

LANDR Audio Inc

Business Activity

LANDR Audio Inc is a software technology company involving automatic music mixing algorithms that mix together individual channels of sound, for example the instruments in a band; effectively replacing the need for a sound engineer and mixing desk. The first product is a hybrid of this for automatic mastering of music.

Founding Academic

Joshua Reiss, Professor of Audio Engineering, School of Electronic Engineering & Computer Science

Website

hvivo

Business Activity

hVIVO is pioneering a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases. Leveraging human disease models in influenza (flu), respiratory syncytial virus (RSV), human rhinovirus (HRV) and other respiratory indications. The hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO, has conducted human challenge studies for multiple clients, both large pharmaceutical and biotech and in a range of challenge models using differing virus challenge agents.

hVIVO recruits volunteers in the UK to take part in its clinical human challenge studies using the ‘FluCamp’ brand.

Founding Academic

Professor John Oxford, Professor of Virology, Blizard Institute

Website

Actual Experience

Business Activity

Actual Experience plc is an algorithm-based software tool that works in real time to predict the service quality that is experienced by individual users of applications on a computer network. It also launches instant, automatic diagnostic traces to isolate the cause of problems as they occur.  The company plans to become the standard measure for user experience of networked applications.

Founding Academic

Professor Jonathan Pitts, Professor of Communication Engineering, School of Electronic Engineering & Computer Science

Website

Neurotex


Business Activity

Biomaterials for nerve repair.

Founding Academic

Prof John Priestly, Blizard Institute